Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:nitric oxide donors'
(id=7017858 ; fe=en:nitric oxide donors ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=2401 creation date=2017-06-25 touchdate=2025-07-16 16:19:55.000)
≈ 51 relations sortantes

  1. en:nitric oxide donors -- r_associated #0: 40 / 1 -> donneurs de no
    n1=en:nitric oxide donors | n2=donneurs de no | rel=r_associated | relid=0 | w=40
  2. en:nitric oxide donors -- r_associated #0: 31 / 0.775 -> donneur d'oxyde nitrique
    n1=en:nitric oxide donors | n2=donneur d'oxyde nitrique | rel=r_associated | relid=0 | w=31
  3. en:nitric oxide donors -- r_associated #0: 31 / 0.775 -> donneurs de monoxyde d'azote
    n1=en:nitric oxide donors | n2=donneurs de monoxyde d'azote | rel=r_associated | relid=0 | w=31
  4. en:nitric oxide donors -- r_associated #0: 30 / 0.75 -> en:mechanism of action qualifier
    n1=en:nitric oxide donors | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=30
  5. en:nitric oxide donors -- r_associated #0: 30 / 0.75 -> en:therapeutic use - qualifier
    n1=en:nitric oxide donors | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=30
  6. en:nitric oxide donors -- r_associated #0: 29 / 0.725 -> en:agonists
    n1=en:nitric oxide donors | n2=en:agonists | rel=r_associated | relid=0 | w=29
  7. en:nitric oxide donors -- r_associated #0: 27 / 0.675 -> en:molecular mechanisms of pharmacological action
    n1=en:nitric oxide donors | n2=en:molecular mechanisms of pharmacological action | rel=r_associated | relid=0 | w=27
  8. en:nitric oxide donors -- r_associated #0: 25 / 0.625 -> en:nitric
    n1=en:nitric oxide donors | n2=en:nitric | rel=r_associated | relid=0 | w=25
  9. en:nitric oxide donors -- r_associated #0: 25 / 0.625 -> en:nitric oxide
    n1=en:nitric oxide donors | n2=en:nitric oxide | rel=r_associated | relid=0 | w=25
  10. en:nitric oxide donors -- r_associated #0: 25 / 0.625 -> oxyde
    n1=en:nitric oxide donors | n2=oxyde | rel=r_associated | relid=0 | w=25
  11. en:nitric oxide donors -- r_associated #0: 24 / 0.6 -> en:enzyme reactivators
    n1=en:nitric oxide donors | n2=en:enzyme reactivators | rel=r_associated | relid=0 | w=24
  12. en:nitric oxide donors -- r_associated #0: 24 / 0.6 -> en:peptidomimetics
    n1=en:nitric oxide donors | n2=en:peptidomimetics | rel=r_associated | relid=0 | w=24
  13. en:nitric oxide donors -- r_associated #0: 23 / 0.575 -> en:vasoprotectant
    n1=en:nitric oxide donors | n2=en:vasoprotectant | rel=r_associated | relid=0 | w=23
  14. en:nitric oxide donors -- r_associated #0: 22 / 0.55 -> en:pharmacokinetic aspects
    n1=en:nitric oxide donors | n2=en:pharmacokinetic aspects | rel=r_associated | relid=0 | w=22
  15. en:nitric oxide donors -- r_associated #0: 22 / 0.55 -> en:standards characteristics
    n1=en:nitric oxide donors | n2=en:standards characteristics | rel=r_associated | relid=0 | w=22
  16. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> agent bloquant adrénergique cardiaque
    n1=en:nitric oxide donors | n2=agent bloquant adrénergique cardiaque | rel=r_associated | relid=0 | w=20
  17. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> agent vasodilatateur
    n1=en:nitric oxide donors | n2=agent vasodilatateur | rel=r_associated | relid=0 | w=20
  18. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> alcoylant
    n1=en:nitric oxide donors | n2=alcoylant | rel=r_associated | relid=0 | w=20
  19. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> antienzyme
    n1=en:nitric oxide donors | n2=antienzyme | rel=r_associated | relid=0 | w=20
  20. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> antimétabolite
    n1=en:nitric oxide donors | n2=antimétabolite | rel=r_associated | relid=0 | w=20
  21. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:alkylating agent
    n1=en:nitric oxide donors | n2=en:alkylating agent | rel=r_associated | relid=0 | w=20
  22. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:alpha-adrenergic agonist
    n1=en:nitric oxide donors | n2=en:alpha-adrenergic agonist | rel=r_associated | relid=0 | w=20
  23. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:alpha-adrenergic antagonist
    n1=en:nitric oxide donors | n2=en:alpha-adrenergic antagonist | rel=r_associated | relid=0 | w=20
  24. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:angiotensin receptor antagonists
    n1=en:nitric oxide donors | n2=en:angiotensin receptor antagonists | rel=r_associated | relid=0 | w=20
  25. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:antacid preparation
    n1=en:nitric oxide donors | n2=en:antacid preparation | rel=r_associated | relid=0 | w=20
  26. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:antienzyme.
    n1=en:nitric oxide donors | n2=en:antienzyme. | rel=r_associated | relid=0 | w=20
  27. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:antifoaming agents
    n1=en:nitric oxide donors | n2=en:antifoaming agents | rel=r_associated | relid=0 | w=20
  28. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:antihypertensive agent
    n1=en:nitric oxide donors | n2=en:antihypertensive agent | rel=r_associated | relid=0 | w=20
  29. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:antilipemic agent
    n1=en:nitric oxide donors | n2=en:antilipemic agent | rel=r_associated | relid=0 | w=20
  30. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:antimetabolite
    n1=en:nitric oxide donors | n2=en:antimetabolite | rel=r_associated | relid=0 | w=20
  31. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:beta-adrenergic antagonist
    n1=en:nitric oxide donors | n2=en:beta-adrenergic antagonist | rel=r_associated | relid=0 | w=20
  32. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:calcium channel blocker
    n1=en:nitric oxide donors | n2=en:calcium channel blocker | rel=r_associated | relid=0 | w=20
  33. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:calcium channel inhibitor
    n1=en:nitric oxide donors | n2=en:calcium channel inhibitor | rel=r_associated | relid=0 | w=20
  34. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:cardiac adrenergic blocking agent
    n1=en:nitric oxide donors | n2=en:cardiac adrenergic blocking agent | rel=r_associated | relid=0 | w=20
  35. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:cardiac agent
    n1=en:nitric oxide donors | n2=en:cardiac agent | rel=r_associated | relid=0 | w=20
  36. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:cardiotonic agent
    n1=en:nitric oxide donors | n2=en:cardiotonic agent | rel=r_associated | relid=0 | w=20
  37. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:cystine depleting agents
    n1=en:nitric oxide donors | n2=en:cystine depleting agents | rel=r_associated | relid=0 | w=20
  38. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:enzyme inhibitor
    n1=en:nitric oxide donors | n2=en:enzyme inhibitor | rel=r_associated | relid=0 | w=20
  39. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:meldonium
    n1=en:nitric oxide donors | n2=en:meldonium | rel=r_associated | relid=0 | w=20
  40. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:mitosis modulators
    n1=en:nitric oxide donors | n2=en:mitosis modulators | rel=r_associated | relid=0 | w=20
  41. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:natriuretic agents
    n1=en:nitric oxide donors | n2=en:natriuretic agents | rel=r_associated | relid=0 | w=20
  42. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:sodium channel blockers
    n1=en:nitric oxide donors | n2=en:sodium channel blockers | rel=r_associated | relid=0 | w=20
  43. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:thrombolytic agent
    n1=en:nitric oxide donors | n2=en:thrombolytic agent | rel=r_associated | relid=0 | w=20
  44. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> en:vasodilating agent
    n1=en:nitric oxide donors | n2=en:vasodilating agent | rel=r_associated | relid=0 | w=20
  45. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> inhibiteur d'enzymes
    n1=en:nitric oxide donors | n2=inhibiteur d'enzymes | rel=r_associated | relid=0 | w=20
  46. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> inhibiteur des canaux calciques
    n1=en:nitric oxide donors | n2=inhibiteur des canaux calciques | rel=r_associated | relid=0 | w=20
  47. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> inhibiteur enzymatique
    n1=en:nitric oxide donors | n2=inhibiteur enzymatique | rel=r_associated | relid=0 | w=20
  48. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> meldonium
    n1=en:nitric oxide donors | n2=meldonium | rel=r_associated | relid=0 | w=20
  49. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> thrombolytique
    n1=en:nitric oxide donors | n2=thrombolytique | rel=r_associated | relid=0 | w=20
  50. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> thrombolytique (médicament)
    n1=en:nitric oxide donors | n2=thrombolytique (médicament) | rel=r_associated | relid=0 | w=20
  51. en:nitric oxide donors -- r_associated #0: 20 / 0.5 -> vasodilatateur
    n1=en:nitric oxide donors | n2=vasodilatateur | rel=r_associated | relid=0 | w=20
≈ 57 relations entrantes

  1. en:vasodilating agent --- r_associated #0: 110 --> en:nitric oxide donors
    n1=en:vasodilating agent | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=110
  2. agent vasodilatateur --- r_associated #0: 106 --> en:nitric oxide donors
    n1=agent vasodilatateur | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=106
  3. vasodilatateur --- r_associated #0: 95 --> en:nitric oxide donors
    n1=vasodilatateur | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=95
  4. antimétabolite --- r_associated #0: 80 --> en:nitric oxide donors
    n1=antimétabolite | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=80
  5. en:antimetabolite --- r_associated #0: 78 --> en:nitric oxide donors
    n1=en:antimetabolite | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=78
  6. inhibiteur enzymatique --- r_associated #0: 73 --> en:nitric oxide donors
    n1=inhibiteur enzymatique | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=73
  7. en:enzyme inhibitor --- r_associated #0: 72 --> en:nitric oxide donors
    n1=en:enzyme inhibitor | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=72
  8. en:meldonium --- r_associated #0: 70 --> en:nitric oxide donors
    n1=en:meldonium | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=70
  9. inhibiteur d'enzymes --- r_associated #0: 70 --> en:nitric oxide donors
    n1=inhibiteur d'enzymes | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=70
  10. meldonium --- r_associated #0: 68 --> en:nitric oxide donors
    n1=meldonium | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=68
  11. antienzyme --- r_associated #0: 65 --> en:nitric oxide donors
    n1=antienzyme | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=65
  12. en:cardiac adrenergic blocking agent --- r_associated #0: 64 --> en:nitric oxide donors
    n1=en:cardiac adrenergic blocking agent | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=64
  13. agent bloquant adrénergique cardiaque --- r_associated #0: 60 --> en:nitric oxide donors
    n1=agent bloquant adrénergique cardiaque | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=60
  14. thrombolytique --- r_associated #0: 49 --> en:nitric oxide donors
    n1=thrombolytique | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=49
  15. en:thrombolytic agent --- r_associated #0: 47 --> en:nitric oxide donors
    n1=en:thrombolytic agent | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=47
  16. thrombolytique (médicament) --- r_associated #0: 46 --> en:nitric oxide donors
    n1=thrombolytique (médicament) | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=46
  17. en:calcium channel blocker --- r_associated #0: 42 --> en:nitric oxide donors
    n1=en:calcium channel blocker | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=42
  18. inhibiteur des canaux calciques --- r_associated #0: 40 --> en:nitric oxide donors
    n1=inhibiteur des canaux calciques | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=40
  19. en:antifoaming agents --- r_associated #0: 38 --> en:nitric oxide donors
    n1=en:antifoaming agents | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=38
  20. en:alpha-adrenergic antagonist --- r_associated #0: 36 --> en:nitric oxide donors
    n1=en:alpha-adrenergic antagonist | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=36
  21. en:alkylating agent --- r_associated #0: 35 --> en:nitric oxide donors
    n1=en:alkylating agent | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=35
  22. en:cardiac agent --- r_associated #0: 35 --> en:nitric oxide donors
    n1=en:cardiac agent | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=35
  23. en:cardiotonic agent --- r_associated #0: 35 --> en:nitric oxide donors
    n1=en:cardiotonic agent | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=35
  24. en:mechanism of action qualifier --- r_associated #0: 35 --> en:nitric oxide donors
    n1=en:mechanism of action qualifier | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=35
  25. en:mitosis modulators --- r_associated #0: 35 --> en:nitric oxide donors
    n1=en:mitosis modulators | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=35
  26. en:molecular mechanisms of pharmacological action --- r_associated #0: 35 --> en:nitric oxide donors
    n1=en:molecular mechanisms of pharmacological action | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=35
  27. en:natriuretic agents --- r_associated #0: 35 --> en:nitric oxide donors
    n1=en:natriuretic agents | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=35
  28. en:peptidomimetics --- r_associated #0: 35 --> en:nitric oxide donors
    n1=en:peptidomimetics | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=35
  29. en:pharmacokinetic aspects --- r_associated #0: 35 --> en:nitric oxide donors
    n1=en:pharmacokinetic aspects | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=35
  30. en:standards characteristics --- r_associated #0: 32 --> en:nitric oxide donors
    n1=en:standards characteristics | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=32
  31. en:therapeutic use - qualifier --- r_associated #0: 32 --> en:nitric oxide donors
    n1=en:therapeutic use - qualifier | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=32
  32. donneur d'oxyde nitrique --- r_associated #0: 31 --> en:nitric oxide donors
    n1=donneur d'oxyde nitrique | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=31
  33. en:calcium channel inhibitor --- r_associated #0: 31 --> en:nitric oxide donors
    n1=en:calcium channel inhibitor | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=31
  34. en:sodium channel blockers --- r_associated #0: 31 --> en:nitric oxide donors
    n1=en:sodium channel blockers | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=31
  35. donneurs de no --- r_associated #0: 30 --> en:nitric oxide donors
    n1=donneurs de no | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=30
  36. en:cystine depleting agents --- r_associated #0: 30 --> en:nitric oxide donors
    n1=en:cystine depleting agents | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=30
  37. en:enzyme reactivators --- r_associated #0: 30 --> en:nitric oxide donors
    n1=en:enzyme reactivators | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=30
  38. en:vasoprotectant --- r_associated #0: 30 --> en:nitric oxide donors
    n1=en:vasoprotectant | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=30
  39. Inhibiteur enzymatique --- r_associated #0: 29 --> en:nitric oxide donors
    n1=Inhibiteur enzymatique | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=29
  40. alcoylant --- r_associated #0: 29 --> en:nitric oxide donors
    n1=alcoylant | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=29
  41. en:agonists --- r_associated #0: 29 --> en:nitric oxide donors
    n1=en:agonists | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=29
  42. en:antilipemic agent --- r_associated #0: 29 --> en:nitric oxide donors
    n1=en:antilipemic agent | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=29
  43. donneurs de monoxyde d'azote --- r_associated #0: 28 --> en:nitric oxide donors
    n1=donneurs de monoxyde d'azote | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=28
  44. en:alpha-adrenergic agonist --- r_associated #0: 28 --> en:nitric oxide donors
    n1=en:alpha-adrenergic agonist | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=28
  45. en:antacid preparation --- r_associated #0: 28 --> en:nitric oxide donors
    n1=en:antacid preparation | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=28
  46. en:antienzyme. --- r_associated #0: 27 --> en:nitric oxide donors
    n1=en:antienzyme. | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=27
  47. en:beta-adrenergic antagonist --- r_associated #0: 27 --> en:nitric oxide donors
    n1=en:beta-adrenergic antagonist | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=27
  48. en:angiotensin receptor antagonists --- r_associated #0: 26 --> en:nitric oxide donors
    n1=en:angiotensin receptor antagonists | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=26
  49. en:antihypertensive agent --- r_associated #0: 26 --> en:nitric oxide donors
    n1=en:antihypertensive agent | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=26
  50. en:calcium channel agonists --- r_associated #0: 25 --> en:nitric oxide donors
    n1=en:calcium channel agonists | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=25
  51. en:potassium channel blockers --- r_associated #0: 25 --> en:nitric oxide donors
    n1=en:potassium channel blockers | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=25
  52. en:radiopharmaceutical compound --- r_associated #0: 25 --> en:nitric oxide donors
    n1=en:radiopharmaceutical compound | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=25
  53. en:antienzyme --- r_associated #0: 23 --> en:nitric oxide donors
    n1=en:antienzyme | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=23
  54. alkylant --- r_associated #0: 21 --> en:nitric oxide donors
    n1=alkylant | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=21
  55. Antimétabolite --- r_associated #0: 10 --> en:nitric oxide donors
    n1=Antimétabolite | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=10
  56. antagonistes du récepteur de l'angiotensine --- r_associated #0: 10 --> en:nitric oxide donors
    n1=antagonistes du récepteur de l'angiotensine | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=10
  57. donneurs de NO --- r_associated #0: 5 --> en:nitric oxide donors
    n1=donneurs de NO | n2=en:nitric oxide donors | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr